Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

STRENSIQ SOLUTION FOR INJECTION 40 MG/ML

Approval Number

SIN17127P

Drug Name

STRENSIQ SOLUTION FOR INJECTION 40 MG/ML

Product Name

STRENSIQ SOLUTION FOR INJECTION 40 MG/ML

Approval Date

October 29, 2024

Registrant

ASTRAZENECA SINGAPORE PTE LTD

Regulatory Information

Registrant

ASTRAZENECA SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

A16AB13

Manufacturer Information

Pharmaceutical Manufacturer

ASTRAZENECA SINGAPORE PTE LTD

Manufacturers

Alexion Pharma International Operations Limited (AAMF)

Patheon Italia S.p.A

Active Ingredients

Ingredient Name

asfotase alfa

Strength

40mg/mL

Drug MonographAsfotase alfa

Documents

Package Inserts

Strensiq Approved PI.pdf

Approved: October 29, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy